Advanced Therapies

CAMBRIDGE, UK, July 23, 2026 AstraZeneca has secured European Commission approval for Etcamah (camizestrant) in combination with a CDK4/6...

WALTHAM, Mass. & BOTHELL, Wash., July 22, 2026 Repligen Corporation has announced a definitive agreement to acquire BioLife Solutions...

SAN DIEGO, Calif., July 7, 2026 Nucleus Biologics has launched CRAIC™ Formulation Finder, a new large language model (LLM)-powered...

OXFORD, England & STAMFORD, Conn., July 8, 2026 Caristo Diagnostics has announced that new clinical evidence supporting its AI-powered...

MILPITAS, Calif. & FREDERICK, Md., July 8, 2026 RoosterBio and Applied StemCell (ASC) have announced a strategic partnership to...

DALLAS, May 27, 2026 Nanoscope Therapeutics Inc., a biotechnology company developing disease-agnostic therapies for retinal degeneration and vision impairment,...

COLUMBUS, Ohio, May 13, 2026 Andelyn Biosciences announced that it has received full certification under the Initiative for Certification...

WALNUT CREEK, Calif., and BEIJING, China, May 11, 2026 Dark Horse Consulting Group (DHCG) and KunTuo Medical Research and...

LEBANON, Indiana, United States – May 6, 2026 Eli Lilly and Company has announced an additional $4.5 billion investment...

PRINCETON, New Jersey, April 30, 2026 Made Scientific, a U.S.-based cell therapy contract development and manufacturing organization (CDMO), announced...